Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2013Drug Research

Development of a Subcutaneous Formulation for Trastuzumab – Nonclinical and Clinical Bridging Approach to the Approved Intravenous Dosing Regimen

View Full Paper
Ask AI
Bookmark
Share

Authors

BBBeate BittnerRoche (Switzerland)WRW. RichterEvangelisches Krankenhaus BielefeldFHFlorence Hourcade‐PotelleretNovartis (Switzerland)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bittner et al. (2013) studied this question.

synapsesocial.com/papers/6a9b9372d8d8bde79ebb0463https://doi.org/10.1055/s-0033-1357211
View Full Paper
Ask AI
Bookmark
Share